Transcripts SRAX, Inc.

Equities

SRAX

US78472M1062

Market Closed - OTC Markets Other stock markets 20:02:50 24/06/2024 BST			5-day change	1st Jan Change
0.35 ^USD	+3,331.37%		-12.48%	+1,047.54%

05-08	DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc..	CI
04-02	SRAX, Inc. announced that it has received $0.075 million in funding	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : SRAX, Inc. - Special Call	17/01/23
Transcript : SRAX, Inc. - Shareholder/Analyst Call	31/12/22
Transcript : SRAX, Inc. - Special Call	24/10/22
Transcript : SRAX, Inc., 2021 Earnings Call, Jun 06, 2022	06/06/22
SRAX, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2022	06/06/22	CI
Transcript : SRAX, Inc., Q4 2021 Earnings Call, Apr 04, 2022	04/04/22
SRAX, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2022	10/01/22	CI
Transcript : SRAX, Inc., Q3 2021 Earnings Call, Nov 15, 2021	15/11/21
SRAX, Inc. Provides Revenue Guidance for Fourth Quarter of 2021 and Reaffirms Revenue Guidance for Full Year of 2021	15/11/21	CI
Transcript : SRAX, Inc., Q2 2021 Earnings Call, Aug 16, 2021	16/08/21
SRAX, Inc. Provides Revenue Guidance for the Third Quarter of 2021	16/08/21	CI
Transcript : SRAX, Inc. - Shareholder/Analyst Call	29/06/21
Transcript : SRAX, Inc., Q1 2021 Earnings Call, May 17, 2021	17/05/21
SRAX, Inc. Provides Revenue Guidance for the Second Quarter of Fiscal 2021	17/05/21	CI
Transcript : SRAX, Inc., Q4 2020 Earnings Call, Mar 29, 2021	29/03/21
SRAX, Inc. Provides Revenue Guidance for the Second Quarter Of Fiscal Year 2021	29/03/21	CI
SRAX, Inc. Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2020; Provides Revenue Guidance for the First Quarter and Full Year 2021	28/01/21	CI
Transcript : SRAX, Inc. - Shareholder/Analyst Call	31/12/20
Transcript : SRAX, Inc., Q3 2020 Earnings Call, Nov 16, 2020	16/11/20
Srax, Inc. Announces Revenue Guidance for Fourth Quarter	16/11/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts SRAX, Inc.

Equities

SRAX

US78472M1062

Transcripts

Filters